8-K: Current report
Published on October 26, 2007
|
UNITED
STATES
|
|||||
|
SECURITIES
AND EXCHANGE COMMISSION
|
|||||
|
Washington,
D.C. 20549
|
|||||
|
FORM
8-K
|
|||||
|
CURRENT
REPORT
|
|||||
|
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of
1934
|
|||||
|
Date
of report (Date of earliest event reported): October 25,
2007
|
|||||
|
IDEXX
LABORATORIES, INC.
|
|||||
|
(Exact
name of registrant as specified in its charter)
|
|||||
|
Delaware
|
000-19271
|
01-0393723
|
|||
|
(State
or other jurisdiction
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
|||
|
of
incorporation)
|
|||||
|
One
IDEXX Drive, Westbrook, Maine
|
04092
|
||||
|
(Address
of principal executive offices)
|
(ZIP
Code)
|
||||
|
207-556-0300
|
|||||
|
(Registrant's
telephone number, including area code)
|
|||||
|
Not
Applicable
|
|||||
|
(Former
name or former address, if changed since last
report)
|
|||||
|
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under
any
of the following provisions (see General Instruction A.2. to Form
8-K):
|
|||||
|
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR
230.425)
|
||||
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
||||
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR
240.14d-2(b))
|
||||
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR
240.13e-4(c))
|
||||
|
Item
2.02
|
Results
of Operations and Financial
Condition.
|
On
October 26, 2007, IDEXX Laboratories, Inc. (the “Company”) announced its
financial results for the quarter ended September 30, 2007. The full text of
the
press release issued in connection with the announcement is furnished as Exhibit
99.1 to this Current Report on Form 8-K.
In
accordance with general instructions to Form 8-K, the information in this Form
8-K and the Exhibit 99.1 attached hereto is being furnished under Item 2.02
and
shall not be deemed “filed” for purposes of Section 18 of the Securities
Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the
liabilities of that section, nor shall it be deemed incorporated by reference
in
any filing under the Securities Act of 1933 or the Exchange Act, except as
expressly set forth by specific reference in such a filing.
|
Item
8.01
|
Other
Events.
|
On
October 25, 2007 the Company’s board of directors approved a two-for-one stock
split of the Company’s outstanding shares of common stock, to be effected in the
form of a 100% stock dividend. Each holder of common stock of record as of
the
close of business on November 5, 2007 will be entitled to one additional share
of common stock for each share of common stock held on such date. The additional
shares of common stock will be distributed on or about November 26, 2007. The
stock split will double the number of outstanding common shares to approximately
61 million based on the number of shares outstanding as of October 22,
2007.
Item
9.01 Financial
Statements and Exhibits.
(d) Exhibits
The
following exhibit relating to Item 2.02 shall be deemed to be furnished, and
not
filed.
|
99.1
|
Press
Release entitled “IDEXX Laboratories Announces Third Quarter Results and
Two-for-One Stock Split,” issued by the company on October 26,
2007.
|
2
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
IDEXX
LABORATORIES, INC.
|
||
|
Date:
October 26, 2007
|
By:
|
/s/
Merilee Raines
|
|
Merilee
Raines
|
||
|
Corporate
Vice President and
Chief
Financial Officer
|
||
3
EXHIBIT
INDEX
|
Exhibit
No.
|
Description
of Exhibit
|
|
99.1
|
Press
Release entitled “IDEXX Laboratories Announces Third Quarter Results and
Two-for-One Stock Split,” issued by the company on October 26, 2007.
|